PMID- 8421651 OWN - NLM STAT- MEDLINE DCOM- 19930217 LR - 20131121 IS - 0190-535X (Print) IS - 0190-535X (Linking) VI - 20 IP - 1 DP - 1993 Jan-Feb TI - Intravenous immunoglobulin in oncology nursing practice. PG - 69-75 AB - Intravenous immunoglobulin (IVIG) is a concentrated form of IgG, also known as gamma globulin, that is derived from the pooled serum of a large number of donors. IVIG contains many types of antibacterial and antiviral antibodies. While its use in certain clinical conditions (e.g., severe combined immunodeficiency) is well-established, other indications still are under investigation. Along with nursing implications for use in inpatient and outpatient settings, the role of IVIG in treating immune thrombocytopenic purpura, chronic lymphocytic leukemia, treatment-induced neutropenia and thrombocytopenia, bone marrow transplantation, and AIDS will be discussed. FAU - Timmerman, P R AU - Timmerman PR AD - Good Samaritan Hospital, Downers Grove, IL. LA - eng PT - Journal Article PT - Review PL - United States TA - Oncol Nurs Forum JT - Oncology nursing forum JID - 7809033 RN - 0 (Immunoglobulin G) RN - 0 (Immunoglobulins, Intravenous) SB - IM MH - Acquired Immunodeficiency Syndrome/drug therapy MH - Antibody Formation MH - Bone Marrow Transplantation MH - Clinical Protocols/standards MH - Drug Costs MH - Drug Hypersensitivity/epidemiology MH - Drug Labeling/standards MH - Humans MH - Immunoglobulin G/immunology MH - Immunoglobulins, Intravenous/administration & dosage/adverse effects/*therapeutic use MH - Incidence MH - Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy MH - Neutropenia/chemically induced/drug therapy MH - Oncology Nursing/*methods MH - Purpura, Thrombocytopenic, Idiopathic/drug therapy MH - Thrombocytopenia/chemically induced/drug therapy MH - World Health Organization RF - 40 EDAT- 1993/01/01 00:00 MHDA- 1993/01/01 00:01 CRDT- 1993/01/01 00:00 PHST- 1993/01/01 00:00 [pubmed] PHST- 1993/01/01 00:01 [medline] PHST- 1993/01/01 00:00 [entrez] PST - ppublish SO - Oncol Nurs Forum. 1993 Jan-Feb;20(1):69-75.